Unassisted Return of Spontaneous Circulation

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)

After delivery, lamotrigine oral clearance declined exponentially back to pre-pregnancy baseline values with a half-life of 0.55 weeks, meaning doses should be tapered to preconception levels within 3

Effect: improvement; CL/F return half-life 0.55 weeks (rate constant k=1.27/week)